Back
Bio-Path Holdings Vs. Theriva Biologics Industry Stock Comparison
Sell
13
BPTH
Bio-Path Holdings
Last Price:
0.79
Seasonality Move:
-1.41%
Sell
44
TOVX
Theriva Biologics
Last Price:
1.29
Seasonality Move:
98.81%
Sell
13
Bio-Path Holdings (BPTH)
is a Sell
Is Bio-Path Holdings a Buy, Sell or Hold?
- The current Bio-Path Holdings [BPTH] share price is $0.80. The Score for BPTH is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- BPTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $1.28. The Score for TOVX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- TOVX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPTH Stock Price Chart
What is Bio-Path Holdings's stock price today?
-
The Bio-Path Holdings share price today is $0.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing slight buying pressure.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight buying pressure.
BPTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 37.75 | Sell |
Chaikin Money Flow: | 4772 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.84 - 1.06) | Sell |
Bollinger Bands (100): | (0.87 - 1.57) | Sell |
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 36.52 | Sell |
Chaikin Money Flow: | 5109 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.3 - 1.86) | Sell |
Bollinger Bands (100): | (1.63 - 5.65) | Sell |
BPTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.83 | Sell |
20-day SMA: | 0.91 | Sell |
50-day SMA: | 0.97 | Sell |
200-day SMA: | 2.62 | Sell |
8-day EMA: | 0.82 | Sell |
20-day EMA: | 0.89 | Sell |
50-day EMA: | 1.02 | Sell |
200-day EMA: | 3.88 | Sell |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.33 | Sell |
20-day SMA: | 1.6 | Sell |
50-day SMA: | 1.97 | Sell |
200-day SMA: | 6.78 | Sell |
8-day EMA: | 1.38 | Sell |
20-day EMA: | 1.55 | Sell |
50-day EMA: | 2.17 | Sell |
200-day EMA: | 6.2 | Sell |
Bio-Path Holdings Earnings Growth & BPTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.23 per share, and an increase next year of $1.62 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Bio-Path Holdings Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theriva Biologics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |